B cell activation and the establishment of Epstein-Barr virus latency.
Open Access
- 1 December 1988
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 168 (6) , 2059-2075
- https://doi.org/10.1084/jem.168.6.2059
Abstract
Linear EBV genomes undergo a transition to the circular form characteristic of latency by 16-20 h post-infection. This transition requires that the infected cells be activated to the G1 stage of the cell cycle. Cellular proliferation and expression of the activation marker CD23 were not required. Nevertheless, 36 h post-infection, only cells expressing CD23 contained covalently closed, circular episomes (CCC), at an average of one copy per cell. Since the presence of CD23 at this time is predictive that a cell will immortalize, we suggest that the presence of CCC is required for CD23 expression and subsequent immortalization. The one CCC present in each CD23+ cell did not undergo amplification until well after the cells had acquired all of the characteristic phenotypic markers of immortalization. Therefore, while amplification is not necessary for proliferation and immortalization, circularization of a single genome is crucial to the establishment and maintenance of latency by EBV.Keywords
This publication has 50 references indexed in Scilit:
- An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.Proceedings of the National Academy of Sciences, 1986
- CONTROL OF HUMAN LYMPHOCYTE-B REPLICATION .2. TRANSFORMING EPSTEIN-BARR-VIRUS EXPLOITS 3 DISTINCT VIRAL SIGNALS TO UNDERMINE 3 SEPARATE CONTROL POINTS IN B-CELL GROWTH1986
- Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.Proceedings of the National Academy of Sciences, 1986
- Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.Proceedings of the National Academy of Sciences, 1986
- B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV)European Journal of Immunology, 1986
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons.Proceedings of the National Academy of Sciences, 1985
- Early events in Epstein-Barr virus infection provide a model for B cell activation.The Journal of Experimental Medicine, 1985
- Evolution of tumours and the impact of molecular oncologyNature, 1985
- Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro.Proceedings of the National Academy of Sciences, 1983